Challenges in the development of an autologous heat shock protein based anti-tumor vaccine

Bibliographic Details
Main Authors: Dirk J. Reitsma, Austin J. Combest
Format: Article
Language:English
Published: Taylor & Francis Group 2012-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.4161/hv.21382
_version_ 1797633006188363776
author Dirk J. Reitsma
Austin J. Combest
author_facet Dirk J. Reitsma
Austin J. Combest
author_sort Dirk J. Reitsma
collection DOAJ
first_indexed 2024-03-11T11:44:41Z
format Article
id doaj.art-8a3e413cb7a04f94bc21cd4610451159
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T11:44:41Z
publishDate 2012-08-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-8a3e413cb7a04f94bc21cd46104511592023-11-09T15:17:18ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2012-08-01881152115510.4161/hv.21382Challenges in the development of an autologous heat shock protein based anti-tumor vaccineDirk J. Reitsma0Austin J. Combest1PPD; Wilmington, NC USAPPD; Wilmington, NC USAhttps://www.tandfonline.com/doi/10.4161/hv.21382VitespenimmunotherapyI-SPYBayesian trial designadaptive trialsOncophage
spellingShingle Dirk J. Reitsma
Austin J. Combest
Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
Human Vaccines & Immunotherapeutics
Vitespen
immunotherapy
I-SPY
Bayesian trial design
adaptive trials
Oncophage
title Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
title_full Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
title_fullStr Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
title_full_unstemmed Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
title_short Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
title_sort challenges in the development of an autologous heat shock protein based anti tumor vaccine
topic Vitespen
immunotherapy
I-SPY
Bayesian trial design
adaptive trials
Oncophage
url https://www.tandfonline.com/doi/10.4161/hv.21382
work_keys_str_mv AT dirkjreitsma challengesinthedevelopmentofanautologousheatshockproteinbasedantitumorvaccine
AT austinjcombest challengesinthedevelopmentofanautologousheatshockproteinbasedantitumorvaccine